Maziar Mike Doustdar
Maziar Mike Doustdar is a prominent Austrian-Iranian business executive, currently serving as the head of international operations for Novo Nordisk, a leading pharmaceutical company specializing in obesity treatments. Based in Zurich, Doustdar oversees a substantial revenue stream for the company, which has become a market leader in innovative weight-loss injections. His career at Novo Nordisk began at the age of 22, and through years of dedication and various roles, he ascended to his current position, demonstrating a remarkable ability to navigate the complexities of the pharmaceutical industry. Known for his approachable leadership style, Doustdar emphasizes the importance of humility in a rapidly growing business segment.
Not in the pool (under ¢1).
Recent news mentions
Maziar Mike Doustdar took over the leadership of Novo Nordisk in August 2021.
Načrt za reševanje danskega pionirja hujšanja
Slovenia· 2025-12-19Maziar Mike Doustdar is the new CEO of Novo Nordisk, facing challenges after losing a bid for Metsera to Pfizer.
Novo Nordisk po porazu s Pfizerjem v novih težavahSlovenia· 2025-11-09Maziar Mike Doustdar is the new boss of Novo Nordisk who froze hiring in August and warned job cuts may follow.
Novo Nordisk to cut staff numbers at Irish business – The Irish Times
Ireland· 2025-09-30
Maziar Mike Doustdar is the CEO of Novo Nordisk and is implementing a major cost-cutting program to address the company's financial challenges.
Novo Nordisk kürzt 9000 Stellen: Sparprogramm gegen Börsenkrise
Switzerland· 2025-09-10
Maziar Mike Doustdar has taken over the leadership of Novo Nordisk.
Vom Börsenstar zum Sorgenkind – findet Novo Nordisk zurück in die Spur?Switzerland· 2025-08-07
Maziar Mike Doustdar has been appointed as the new President and CEO of Novo Nordisk.
Wirtschaft: die wichtigsten MeldungenSwitzerland· 2025-07-31
Maziar Mike Doustdar replaced Lars Fruergaard Jørgen as CEO of Novo Nordisk on August 7.
Crollo di Novo Nordisk, la concorrenza e le strategie di prezzo mettono a rischio il colosso dei farmaci per la perdita di peso
Italy· 2025-07-30
Maziar Mike Doustdar will take over as chief executive on 7 August.
Wegovy maker Novo Nordisk warns of slower profits as rivals bite
United Kingdom· 2025-07-29
Maziar Mike Doustdar has dedicated his entire working life to Novo Nordisk.
Valget af Mike Doustdar sender et signal, der især handler om penge
Denmark· 2025-07-29Maziar Mike Doustdar has been appointed as the new CEO of Novo Nordisk.
Novo Nordisk rasar på börsen efter sänkta prognoser
Sweden· 2025-07-29
Maziar Mike Doustdar has been appointed as the new CEO of Novo Nordisk.
Novo Nordisk udpeger ny topchef midt i aktiestyrtdykDenmark· 2025-07-29
Maziar Mike Doustdar is the head of international business for the Danish pharmaceutical group Novo Nordisk.
keine Engpässe mehr bei AbnehmspritzenSwitzerland· 2025-04-02